-
PublishedSeptember 17, 2019
Jimmy Carter says he couldn’t have managed presidency at 80
The 94-year-old former president didn’t mention any of the presidential hopefuls by name, but two leading 2020 candidates are nearing 80.
-
PublishedSeptember 17, 2019
Democrats push ahead with short-term bill to avoid shutdown
House leaders are keeping a short-term, government-wide spending measure that’s needed to prevent a government shutdown free of controversy.
-
PublishedSeptember 17, 2019
Lewandowski, House Democrats spar at impeachment hearing
Democrats’ first impeachment hearing quickly turned hostile as their sole witness, former Trump campaign manager Corey Lewandowski, stonewalled many of their questions.
-
PublishedSeptember 17, 2019
Pompeo making spur-of-the-moment trip to Mideast as Iran rules out talks
The secretary of state will visit Saudi Arabia and the United Arab Emirates amid concerns that rising tensions could spiral into a military conflict.
-
PublishedSeptember 17, 2019
U.K. Supreme Court weighs whether Boris Johnson broke the law in suspending Parliament
The court proceedings could have far-reaching implications for the balance of power between the legislature, the executive and the judiciary.
-
PublishedSeptember 17, 2019
Student debt among the factors driving a new bump in Army recruiting
Leaders say they’ll meet their enlistment goal at the end of this month, a year after they failed to make their recruiting numbers.
-
PublishedSeptember 17, 2019
Three things to watch for from the Federal Reserve on Wednesday
The Fed is widely expected to announce a second interest rate cut Wednesday, against the backdrop of a solid if vulnerable U.S. economy now in its 11th year of expansion.
-
PublishedSeptember 17, 2019
‘Blood money’? Purdue settlement would rely on future opioid sales
Opioids, including painkillers like OxyContin and street drugs like heroin and fentanyl, have been blamed for more than 400,000 deaths in the U.S. in the last two decades.
-
PublishedSeptember 17, 2019
‘Jeopardy!’ host Alex Trebek says he’s resumed chemotherapy
Trebek says he’s had a setback in his fight against pancreatic cancer and is back in chemotherapy after a brief period of optimism.
-
PublishedSeptember 15, 2019
Employers fear squeeze from genetic cures that cost millions
New gene therapies are just one component of the relentless rise in employers’ medical costs, which are projected to climb 6 percent next year.
- ← Previous Page
- 1
- …
- 283
- 284
- 285
- 286
- 287
- …
- 294
- Next Page →